Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_assertion type Assertion NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_head.
- NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_provenance.
- NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_assertion evidence source_evidence_literature NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_provenance.
- NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_assertion SIO_000772 20959405 NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_provenance.
- NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_assertion wasDerivedFrom gad-20150221 NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_provenance.
- NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_assertion wasGeneratedBy ECO_0000203 NP124751.RA4sanwQuaLsGmcaQ3BVr8NtrUlMr8bv-GSjZ_EAgmQ8M130_provenance.